Bristol Myers Squibb to Showcase Next-Generation Cancer Modalities and Leadership Across Solid Tumors at ESMO 2026
Go back to Bristol Myers Squibb to Showcase Next-Generation Cancer Modalities and Leadership Across Solid Tumors at ESMO 2026| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 60.86 -0.82 (1.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.68 | 52 Week High | $77.12 | |||
| Open | $61.50 | 52 Week Low | $49.03 | |||
| Day High | $61.81 | P/E | 39.52 | |||
| Day Low | $60.69 | EPS | $1.54 | |||
| Volume | 3,277,148 | |||||



